- Citations, last 5 years
- 17.1k
- Works, last 5 years
- 1 077
- h-index
- 614
- Scientists listed
- 138
- Grants since 2016
- 36
Grants received
2026–2029 · award
The Role of Microglia in Neurofibromatosis Type 1 Cognitive Phenotypes
Sarah Borrie · Vlaams Instituut voor Biotechnologie · funded by Neurofibromatosis Therapeutic Acceleration Program
2025–2027 · award
Targeting RAS for schwannoma therapy
Anna Sablina · Vlaams Instituut voor Biotechnologie · funded by Children's Tumor Foundation
2025 · research · Gram-Negative Antibiotic Discovery Innovator (Gr-ADI)
Nature-Inspired Discovery of Novel Anti-Klebsiella Drugs
Joleen Masschelein · Vlaams Instituut voor Biotechnologie · funded by Novo Nordisk Fonden
2025–2027 · research · Alzheimer's Disease Research: Standard
Leveraging humanised microglia models to unravel C9orf72 gain and loss of function synergistic mechanisms in FTD
Laura Fumagalli · Vlaams Instituut voor Biotechnologie · funded by BrightFocus Foundation
2024–2027 · research · Alzheimer's Disease Research: Standard
Decoding neuron- and microglial-specific molecular mechanisms underlying Presenilin2 function in familial Alzheimer's disease
Willem Annaert · Vlaams Instituut voor Biotechnologie · funded by BrightFocus Foundation
2024 · research · AARF-D
Structural and mechanistic understanding of gamma-secretase modulation
Mohamed Soliman · Vlaams Instituut voor Biotechnologie · funded by Alzheimer's Association
2024–2026 · award
Investigate therapeutic potential of the extracellular matrix to combat NMJ loss
Graciana De Azambuja · Vlaams Instituut voor Biotechnologie · funded by ALS Association
2024–2029 · research · R01
The TMEM106B-GRN-TDP43 triad: leveraging human samples and humanized models to unravel FTLD-TDP disease mechanisms
Renzo Mancuso · Vlaams Instituut voor Biotechnologie · funded by National Institutes of Health
2024–2026 · research · R21
Mapping ductal carcinoma in situ in space and time to reveal biomarkers that can predict invasive risk
Colinda Scheele · Vlaams Instituut voor Biotechnologie · funded by National Institutes of Health
2024–2027 · research · Alzheimer's Disease Research: Standard
Modulation of Microglia-T cells Cross talk in Alzheimer’s disease
Emanuela Pasciuto · Vlaams Instituut voor Biotechnologie · funded by BrightFocus Foundation
2024–2029 · research · R01
The TMEM106B-GRN-TDP43 triad: leveraging human samples and humanized models to unravel FTLD-TDP disease mechanisms
Renzo Mancuso · Vlaams Instituut voor Biotechnologie · funded by National Institutes of Health
2024–2026 · research · R21
Mapping ductal carcinoma in situ in space and time to reveal biomarkers that can predict invasive risk
Colinda Scheele · Vlaams Instituut voor Biotechnologie · funded by National Institutes of Health
2023–2025 · award
Understanding the role of mtDNA mutations and electron transport chain function in thyroid cancer
Celia De La Calle Arregui · Vlaams Instituut voor Biotechnologie · funded by Human Frontier Science Program
2023 · research · E2A
Studying the role of microglia-specific endolysosomal dysfunction in AD
Bart De Strooper · Vlaams Instituut voor Biotechnologie · funded by Alzheimer's Association
2023–2027 · fellowship · EMBO Young Investigator
Investigating the functional heterogeneity of macrophages in the inflamed liver
Charlotte Scott · Vlaams Instituut voor Biotechnologie · funded by European Molecular Biology Organization
2023–2026 · research · Development Grant
Unraveling the contribution of local translation to NMJ degeneration in FUS-ALS
Diana Piol · Vlaams Instituut voor Biotechnologie · funded by Muscular Dystrophy Association
2023 · research · AARG
Exploring the Human Microglial Secretome in Alzheimer’s Disease
Renzo Mancuso · Vlaams Instituut voor Biotechnologie · funded by Alzheimer's Association
2023–2026 · research · Alzheimer's Disease Research: Standard
Elucidating the mechanisms of action of Gamma-secretase modulators (GSMs) to facilitate structure-based design of next-generation therapeutics
Lucía Chávez-Gutiérrez · Vlaams Instituut voor Biotechnologie · funded by BrightFocus Foundation
2022–2027 · research · R01
Heterotypic amyloid interactions as modulators of selective cellular vulnerability
Frederic Rousseau · Vlaams Instituut voor Biotechnologie · funded by National Institutes of Health
2022–2027 · research · R01
Heterotypic amyloid interactions as modulators of selective cellular vulnerability
Frederic Rousseau · Vlaams Instituut voor Biotechnologie · funded by National Institutes of Health
2022–2027 · research · R01
Heterotypic amyloid interactions as modulators of selective cellular vulnerability
Frederic Rousseau · Vlaams Instituut voor Biotechnologie · funded by National Institutes of Health
2022–2027 · research · R01
Heterotypic amyloid interactions as modulators of selective cellular vulnerability
Frederic Rousseau · Vlaams Instituut voor Biotechnologie · funded by National Institutes of Health
2021–2026 · research · Global Health
Vlaams Instituut voor Biotechnologie - to identify alternative hosts and alternative formats to reduce the time and COGS for manufacturing of biologics for use in LMICs
Vlaams Instituut voor Biotechnologie · funded by Bill and Melinda Gates Foundation
2021–2023 · research · Alzheimer's Disease Research: Standard
From genetics to the cellular phase of Alzheimer's disease: untangling the role of lipid pathways in microglia responses to amyloid pathology
Renzo Mancuso · Vlaams Instituut voor Biotechnologie · funded by BrightFocus Foundation
2020 · research · Essential Open Source Software for Science (EOSS)
dynverse: A Toolkit for Studying Cell Development with Single-Cell Omics
Yvan Saeys · Vlaams Instituut voor Biotechnologie · funded by Chan Zuckerberg Initiative
2020–2022 · research · ["Rubicon"]
Eosinophil functional heterogeneity in health and disease
Drs. S. Schetters · Vlaams Instituut voor Biotechnologie · funded by ZonMw
2020 · award
Context matters: dissecting metabolic heterogeneity in the tumor niche
Jiska Van Der Reest · Vlaams Instituut voor Biotechnologie · funded by Human Frontier Science Program
2020–2023 · research · Alzheimer's Disease Research: Standard
Nanobodies stabilizing gamma secretase-APP interactions as novel therapeutics for Alzheimer's
Lucía Chávez-Gutiérrez · Vlaams Instituut voor Biotechnologie · funded by BrightFocus Foundation
2019 · research · AARF
Astroglia and Functional Brain Network Disruptions in Early AD Pathology
Disha Shah · Vlaams Instituut voor Biotechnologie · funded by Alzheimer's Association
2019 · research · AARF
Chaperone Regulated Protein Turnover in Tau Mediated Neurodegeneration
Valerie Uytterhoeven · Vlaams Instituut voor Biotechnologie · funded by Alzheimer's Association
2019–2023 · award
Elucidating the development of biological optical nanostructures
Matthew Shawkey · Vlaams Instituut voor Biotechnologie · funded by Human Frontier Science Program
2018 · research · AARG
Role of Regulatory T cells in Alzheimer`s disease
Adrian Liston · Vlaams Instituut voor Biotechnologie · funded by Alzheimer's Association
2017–2021 · grant · Residual Award
Hungry for knowledge elucidating the role of liver Kupffer cells in instructing the immune response against fed and intestinally-derived antigens.
Dr Charlotte L Scott · Vlaams Instituut voor Biotechnologie · funded by Wellcome Trust
2016 · research · AARF
Somatic mutations as pathogenic drivers in sporadic Alzheimer’s disease
Carlo Sala Frigerio · Vlaams Instituut voor Biotechnologie · funded by Alzheimer's Association
2016 · research · AARF
Selective vulnerability of interneurons in Alzheimer’s disease
Heather Rice · Vlaams Instituut voor Biotechnologie · funded by Alzheimer's Association
2016–2021 · research · R01
Inter-regulatory function of immune-modulation and angiogenesis in cancer
Gabriele Bergers · Vlaams Instituut voor Biotechnologie · funded by National Institutes of Health
